Medicare committee recommends expensi...

Medicare committee recommends expensive drug for some prostate-cancer patients

There are 1 comment on the Medical News story from Nov 19, 2010, titled Medicare committee recommends expensive drug for some prostate-cancer patients. In it, Medical News reports that:

"A new treatment for prostate cancer called Provenge won a vote of confidence from a Medicare coverage advisory committee Wednesday, suggesting the federal program is likely to pay for the $93,000-per-patient medicine,"  The Wall Street Journal reports.

Join the discussion below, or Read more at Medical News.

ed simmons


#1 Nov 20, 2010
why do thet say the prce is high ,texterone ..with radiation ,chemo,medical follow ups ,over 200,000....welfare having 5...7...10 kids ..=60,80,100,000. dollars ..nothing said about this the seniors that need dndn ,that paid into the system,40,50,years ,they deny ,ssraises they take away ,is this the great american ,system ..??

Tell me when this thread is updated:

Subscribe Now Add to my Tracker

Add your comments below

Characters left: 4000

Please note by submitting this form you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Dendreon Discussions

Title Updated Last By Comments
News Dendreon's good news may help these three micro... (Nov '10) Sep '13 Harrison 3
News FDA May Approve Revolutionary Cancer Vaccine (Apr '10) Sep '13 Howard 2
News Stock Losers: Tenet Healthcare Corp, Dendreon C... (Apr '13) Apr '13 Beta Jewelry 1
News Exclusive: Questionable data propped up cancer ... (Oct '12) Oct '12 Theodore J Cohen 1
News Dendreon Will Sink If Provenge Fails (Apr '12) Apr '12 Theodore Jerome C... 1
News Seattle-based Dendreon to cut 500 jobs, slash s... (Sep '11) Sep '11 HumanSpirit 1
Dendreon falls again after gain yesterday (Mar '11) Mar '11 Rita 1
More from around the web